Europe’s medicine regulator adds extremely rare autoimmune disorder as possible side effect of AstraZeneca

PHOTO: John Twohig/Flickr

An extremely rare autoimmune disorder, Guillain-Barré syndrome, has been added as a possible side effect of the AstraZeneca Covid vaccine. The side-effect was noted by Europe’s medicine regulator.

The European Medicines Agency says a causal relationship between the syndrome and AstraZeneca is “at least a reasonable possibility”. They made their assessment based on 833 cases of Guillain-Barré syndrome being reported out of 592 million doses administered by July 31. The agency emphasised that the side effect is very rare, in fact, it is in the lowest frequency of side effects category the EMA has. They also emphasised that the advantages of the vaccine far outweigh the risks.

The U.S. FDA has attached a warning about Guillain-Barré syndrome being a possible side effect of the Johnson & Johnson’s vaccine. While serious side effects from vaccines are considered very rare, Thailand had previously offered a 100,000 baht compensation for anyone who experienced adverse side effects that prevented them from working due to a vaccine. They upped it to 400,000 baht if the patient dies.

For more information on Covid-19 Insurance, CLICK HERE.

Related news


Covid-19 NewsWorld News

Join the conversation and have your say on Thailand news published on The Thaiger.

Thaiger Talk is our new Thaiger Community where you can join the discussion on everything happening in Thailand right now.

Please note that articles are not posted to the forum instantly and can take up to 20 min before being visible. Click for more information and the Thaiger Talk Guidelines.

Jack Connor

Jack is from the USA, has a B.A. in English, and writes on a variety of topics. He lives in Thailand.